Even though FLT3 inhibition may also ameliorate the poor prognosis of FLT3-ITD AML in children (Pollard et al., 2022), the proportion of children with this target is far less predominant compared to adults. The gene discussed is FLT3; the disease is acute myeloid leukemia.